415 related articles for article (PubMed ID: 25062617)
1. Mathematical modeling for novel cancer drug discovery and development.
Zhang P; Brusic V
Expert Opin Drug Discov; 2014 Oct; 9(10):1133-50. PubMed ID: 25062617
[TBL] [Abstract][Full Text] [Related]
2. Computational modeling in melanoma for novel drug discovery.
Pennisi M; Russo G; Di Salvatore V; Candido S; Libra M; Pappalardo F
Expert Opin Drug Discov; 2016 Jun; 11(6):609-21. PubMed ID: 27046143
[TBL] [Abstract][Full Text] [Related]
3. Mathematical modeling in cancer drug discovery.
Wang Z; Deisboeck TS
Drug Discov Today; 2014 Feb; 19(2):145-50. PubMed ID: 23831857
[TBL] [Abstract][Full Text] [Related]
4. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
Ruggeri BA; Camp F; Miknyoczki S
Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
[TBL] [Abstract][Full Text] [Related]
5. Current mathematical models for cancer drug discovery.
Carrara L; Lavezzi SM; Borella E; De Nicolao G; Magni P; Poggesi I
Expert Opin Drug Discov; 2017 Aug; 12(8):785-799. PubMed ID: 28595492
[TBL] [Abstract][Full Text] [Related]
6. In silico analyses for the discovery of tuberculosis drug targets.
Chung BK; Dick T; Lee DY
J Antimicrob Chemother; 2013 Dec; 68(12):2701-9. PubMed ID: 23838951
[TBL] [Abstract][Full Text] [Related]
7. Applications and limitations of in silico models in drug discovery.
Sacan A; Ekins S; Kortagere S
Methods Mol Biol; 2012; 910():87-124. PubMed ID: 22821594
[TBL] [Abstract][Full Text] [Related]
8. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
9. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived tumour xenografts as models for breast cancer drug development.
Marangoni E; Poupon MF
Curr Opin Oncol; 2014 Nov; 26(6):556-61. PubMed ID: 25188472
[TBL] [Abstract][Full Text] [Related]
11. Informatics Approaches for Predicting, Understanding, and Testing Cancer Drug Combinations.
Tang J
Methods Mol Biol; 2017; 1636():485-506. PubMed ID: 28730498
[TBL] [Abstract][Full Text] [Related]
12. Characterizing and optimizing human anticancer drug targets based on topological properties in the context of biological pathways.
Zhang J; Wang Y; Shang D; Yu F; Liu W; Zhang Y; Feng C; Wang Q; Xu Y; Liu Y; Bai X; Li X; Li C
J Biomed Inform; 2015 Apr; 54():132-40. PubMed ID: 25724580
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings.
Nandekar PP; Sangamwar AT
Expert Opin Drug Discov; 2012 Sep; 7(9):771-89. PubMed ID: 22716293
[TBL] [Abstract][Full Text] [Related]
14. Mathematical modeling of cancer progression and response to chemotherapy.
Sanga S; Sinek JP; Frieboes HB; Ferrari M; Fruehauf JP; Cristini V
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1361-76. PubMed ID: 17069522
[TBL] [Abstract][Full Text] [Related]
15. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
16. Multiscale mathematical modeling to support drug development.
Nordsletten DA; Yankama B; Umeton R; Ayyadurai VA; Dewey CF
IEEE Trans Biomed Eng; 2011 Dec; 58(12):3508-12. PubMed ID: 22042123
[TBL] [Abstract][Full Text] [Related]
17. Predictive systems biology approach to broad-spectrum, host-directed drug target discovery in infectious diseases.
Felciano RM; Bavari S; Richards DR; Billaud JN; Warren T; Panchal R; Krämer A
Pac Symp Biocomput; 2013; ():17-28. PubMed ID: 23424108
[TBL] [Abstract][Full Text] [Related]
18. Targeted approaches to childhood cancer: progress in drug discovery and development.
Hirsch S; Marshall LV; Carceller Lechon F; Pearson AD; Moreno L
Expert Opin Drug Discov; 2015 May; 10(5):483-95. PubMed ID: 25840490
[TBL] [Abstract][Full Text] [Related]
19. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
LaBarbera DV; Reid BG; Yoo BH
Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
[TBL] [Abstract][Full Text] [Related]
20. Mathematical modeling analysis of intratumoral disposition of anticancer agents and drug delivery systems.
Popilski H; Stepensky D
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):767-84. PubMed ID: 25813659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
